Arequipa, the second-largest city in Peru, and Nairobi, the capital of Kenya, now join nine other cities* in benefitting from C/Can’s guidance and expertise to identify, plan and execute priority cancer care solutions adapted to the city’s resources.
Peru recorded nearly 70,000 new cases of cancer and 35,000 cancer-related deaths in 2020, with figures expected to reach 123,000 cases and 65,000 deaths in 2040 based on current trends. The cancer burden in Kenya is expected to more than double in the next twenty years, from just over 42,000 cases and 27,000 deaths in 2020 to 95,000 new cases and 64,000 deaths in 2040.
“The global health pandemic has shed more light on the importance of maintaining a resilient health system to support patients. In many countries, national health authorities are struggling to address the pandemic in addition to existing health challenges. As a result, cities are becoming even more critical in leading efforts to provide quality cancer care. We look forward to our next call for applications in 2023.”
– Dr Susan Henshall, CEO of City Cancer Challenge (C/Can)
Launched by UICC at the 2017 World Economic Forum, City Cancer Challenge (C/Can) became a standalone foundation in 2019, while continuing to work closely with UICC’s network of nearly 1,200 members in 172 countries.
“Thanks to C/Can’s efforts, more cities in low-resource settings are able to develop and implement efficient cancer control policies. Adding Arequipa and Nairobi to its portfolio is a fantastic way to start 2022 and celebrate C/Can’s third anniversary as a standalone foundation. We look forward to seeing them expand with more cities in the years to come.”
– Dr Cary Adams, CEO of UICC
*11 cities that are part of C/Can’s mission around the world
Arequipa (Peru), Asuncion (Paraguay), Cali (Colombia), Greater Petaling (Malaysia), Kigali (Rwanda), Kumasi (Ghana), Leon (Mexico), Porto Alegre (Brazil), Tbilisi (Georgia) and Yangon (Myanmar).